Manifold MarketsGeen KYCGeverifieerde afwikkelingsgegevensRedelijk gekalibreerdWaarschuwing datakwaliteitBrongegevens verslechterd
Gegevens van 26 okt 2026, 07:57 UTC · beleid pm-quality-4
Huidige gemeenschapsvoorspellingJa 54.8%
Voorspellers
16
Vraagtype
binary
Methodologie
Play-money forecasting platform
Brontype
Voorspelling
Marktdata
Bijgewerkt 10 uur geleden
Verouderd21 feb 23, 20:20 UTC31 dec 27, 22:59 UTC
Trends
Gerelateerde Markten
Gerelateerde vragen voor context, geen vergelijking van gelijkwaardige contracten.
Will FDA approve any mRNA vaccine against prostate adenocarcinoma before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of human papillomavirus infection before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against Lyme disease before 2028?
Manifold MarketsWill FDA approve any mRNA vaccine against any type of herpes simplex infection before 2028?
Manifold MarketsAny vaccine against Alzheimer's disease to be safe and effective by the end of 2027?
FutuurWill the FDA approve intismeran autogene (V940/mRNA-4157)?
KalshiRegels
Resolves YES if the FDA grants full approval for the commercial sale of any mRNA-based vaccine for the treatment of melanoma in the United States before January 1, 2028.
- This does not include emergency use authorization or other forms of limited authorization.
- Resolves NO otherwise.
